Hung‐Wei Wang
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
-
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
- Cytomegalovirus and herpesvirus research
Papers in
- Epidemiology 26
- Liver Disease Diagnosis and Treatment 21
- Hepatitis B Virus Studies 12
- Cytomegalovirus and herpesvirus research 3
- Hepatology 24
- Hepatitis C virus research 15
- Hepatocellular Carcinoma Treatment and Prognosis 9
- Liver Disease and Transplantation 3
- Co-authors
- Cheng‐Yuan Peng (22 shared papers)Wei‐Fan Hsu (20 shared papers)Guan‐Tarn Huang (12 shared papers)Hsueh‐Chou Lai (18 shared papers)Wen‐Pang Su (16 shared papers)Po‐Heng Chuang (11 shared papers)Sheng‐Hung Chen (13 shared papers)Ting‐Yi Wang (1 shared paper)
- Journals
- PLoS ONE (4 papers)Medicine (3 papers)Cancers (3 papers)Liver International (1 paper)Scientific Reports (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Hung‐Wei Wang
33 papers receiving 366 citations
Peers
Comparison fields: 5 of 72
- Hepatology 207
- Epidemiology 235
- Cancer Research 32
- Nephrology 15
- Pathology and Forensic Medicine 34
Countries citing papers authored by Hung‐Wei Wang
This map shows the geographic impact of Hung‐Wei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung‐Wei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung‐Wei Wang more than expected).
Fields of papers citing papers by Hung‐Wei Wang
This network shows the impact of papers produced by Hung‐Wei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung‐Wei Wang. The network helps show where Hung‐Wei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung‐Wei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 45 | |
| 2 | 2017 | 38 | |
| 3 | 2015 | 35 | |
| 4 | 2015 | 28 | |
| 5 | 2023 | 26 | |
| 6 | 2018 | 22 | |
| 7 | Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience. | 2020 | 16 |
| 8 | Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies. | 2021 | 16 |
| 9 | 2019 | 15 | |
| 10 | 2021 | 12 | |
| 11 | 2023 | 12 | |
| 12 | 2020 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2018 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2020 | 7 | |
| 17 | 2022 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 5 | |
| 20 | Serum miR-21 correlates with the histological stage of chronic hepatitis B-associated liver fibrosis. | 2019 | 5 |
About Hung‐Wei Wang
Hung‐Wei Wang is a scholar working on Epidemiology, Hepatology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 37 papers that have together received 370 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (21 papers), Hepatitis C virus research (15 papers), Hepatitis B Virus Studies (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer, Lipids, and Metabolism (4 papers), Cytomegalovirus and herpesvirus research (3 papers), Liver Disease and Transplantation (3 papers) and Parathyroid Disorders and Treatments (2 papers). The work is most often cited by research in Hepatology (207 citations), Epidemiology (235 citations), Cancer Research (32 citations), Nephrology (15 citations) and Pathology and Forensic Medicine (34 citations). Hung‐Wei Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Cheng‐Yuan Peng, Wei‐Fan Hsu, Guan‐Tarn Huang, Hsueh‐Chou Lai, Wen‐Pang Su, Po‐Heng Chuang, Sheng‐Hung Chen, Ting‐Yi Wang, Chia‐Hsin Lin and Cheng‐Tang Chiu. Their work appears in journals such as PLoS ONE, Medicine, Cancers, Liver International and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.